Pulmonx Corp reports results for the quarter ended in September - Earnings Summary

Pulmonx

03/11/2022 22:48

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 38
cents​​ per share for the quarter ended in September. The mean
expectation of seven analysts for the quarter was for a loss
of 40 cents per share.
    * Revenue rose 1.8% to $13.50 million from a year ago;
analysts
expected $14.92 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 38
cents​.
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulmonx Corp shares had fallen by 18.1% this quarter and
lost 57.5% so far this year.
    * The company reported a quarterly loss of $14.17 million.
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$23.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 10:48 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.40          -0.38          Beat
 Jun. 30 2022      -0.41          -0.40          Beat
 Mar. 31 2022      -0.37          -0.43          Missed
 Dec. 31 2021      -0.36          -0.35          Beat